General Information


DRACP ID  DRACP01995

Peptide Name  

Sequence  GFWARIGKVFAAVKNL

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma EC50=101±4 µM Not available Not available 1

Hemolytic Activity  Human erythrocytes: Not active up to 400 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01995

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C86H133N23O18

Absent amino acids  CDEHMPQSTY

Common amino acids  A

Mass  204489

Pl  11.82

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  86

Hydrophobicity  63.75

Aliphatic Index  103.75

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  366.67

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29679519

Title  Designing Anticancer Peptides by Constructive Machine Learning

Doi 10.1002/cmdc.201800204

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_14297

DRACP is developed by Dr.Zheng's team.